Drug-resistant tuberculosis: challenges and opportunities for diagnosis and treatment

With an estimated incidence of 490 000 cases in 2016, multidrug resistant tuberculosis (TB), against which key first-line anti-tuberculars are less efficacious, presents major challenges for global health. Poor treatment outcomes coupled with a yawning treatment gap between those in need of second-l...

Descripción completa

Detalles Bibliográficos
Autores principales: Koch, Anastasia, Cox, Helen, Mizrahi, Valerie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Science Ltd 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6219890/
https://www.ncbi.nlm.nih.gov/pubmed/29885623
http://dx.doi.org/10.1016/j.coph.2018.05.013

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6219890/
https://www.ncbi.nlm.nih.gov/pubmed/29885623
http://dx.doi.org/10.1016/j.coph.2018.05.013

Ejemplares similares